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Abstract 
Glycosylation is a fundamental process in cellular life, conferring structural and functional 
properties to proteins and lipids. In order for glycosylation to take place properly, a series of 
carefully regulated steps must be carried out in specific organelles of the cell. The Golgi apparatus 
is one of the key organelles where this post-translational modification is carefully controlled by a 
series of steps in a process known as vesicle trafficking. This multi-layered mechanism has many 
key phases by which vesicles loaded with cargo are transported from one membrane 
compartment to another. Glycosylation enzymes make up this cargo and the distribution of these 
proteins throughout the cisternal compartments of the Golgi is crucial for proper glycosylation to 
take place. One of the steps of vesicle trafficking is tethering, a process regulated by various 
proteins including the Conserved Oligomeric Golgi (COG) complex. Defects in subunits of the COG 
complex leads to perturbations in glycosylation which consequently can result in alterations of 
cellular functional homeostasis. 
In this project we utilise Drosophila melanogaster (Dm) as a model organism to try and 
understand more about the role of COG in vesicle trafficking and glycosylation both in vitro and in 
vivo. To achieve these aims, using COG mutants, we have carried out N- and O-linked glycan 
profiling and flight test analysis in an effort to connect COG defects in vivo to altered glycan 
patterns in vitro. Also using a yeast-two-hybrid (Y2H) approach we looked at COG-Rab interactions 
to observe how well conserved mammalian-invertebrate trafficking interactions are. What we 
found are not only functional implications of COG in determining Drosophila glycan synthesis and 
flight ability, but also evidence of evolutionary conservation during interactions associated with 
membrane trafficking events. 
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1. Introduction 
Glycobiology can be defined as the study of carbohydrates in cellular life, accounting for their 
structure, biosynthesis and functional implications in nature. Included in this field are glycans 
which are oligosaccharide structures covalently bound to proteins and lipids during glycosylation. 
However unlike other polymeric structures in biology such as proteins and nucleic acids, our 
understanding of glycans remains limited in comparison. This is attributable to the fact that 
glycans lack a template sequence or code to confer structural properties. Consequently the 
resultant agglomeration of glycan structures in a cell or organism (glycome) is highly 
heterogeneous meaning sensitive experimental approaches are essential to elucidate glycan 
structure and function. 
Glycosylation is one of the more prevalent types of post-translational modification in eukaryotes 
with roughly one fifth of all proteins in the swiss-prot database found to be glycosylated, a large 
proportion of these existing in eukaryotic systems [1]. It is therefore not surprising that 
glycosylation is a fundamental process in assigning functional specificity to molecules. Glycan-
specific roles are prevalent in a multitude of scenarios, for instance by influencing cell surface 
signalling or determining immunogenicity during immune responses [2, 3]. Such roles can be 
perturbed following defects in normal glycan processing which can consequently result in forms 
of disease. Faulty glycosylation has been implicated in a variety of conditions most notably 
Congenital disorders of glycosylation (CDG’s) which exhibit highly pleiotropic phenotypes [4]. 
Moreover other diseases have been associated with improper glycosylation such as Alzheimer’s 
[5] and cancer [6]. However despite much already being known about glycan functions in biology, 
due to the complexity of the field, more remains to be unveiled. The elucidation of glycan roles 
have and continue to be achieved following studies on the Golgi apparatus, the organelle where 
glycosylation chiefly takes place. 
Studies in glycosylation have frequently been carried out in mammalian cell types using in vitro 
experimental approaches. Although this provides further insight into glycosylation, the use of in 
vivo systems aids to compile evidence for glycan roles at a multicellular, whole organism level. A 
key function of glycans is mediating cell-tissue interactions, a feature which cannot be 
recapitulated using simple cell culture based approaches.  Identification of glycan-specific roles 
have been uncovered using mutation-based manipulations of glycosylation pathways in model 
organisms such as fruit flies [7] and nematode worms [8]. Such model systems are a useful tool for 
glycosylation studies in comparison with humans due to their high sequence homology at the 
DNA and protein level, as well as their simple life cycles and multicellular composition. 
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1.1 Glycosylation 
Proteins and lipids are the molecules which specifically undergo glycosylation, the former being 
the subject of this project. A variety of different types of protein glycosylation exist, the most 
common being N-and O-linked. N-linked glycosylation differs from O-linked in that N-linked glycan 
processing initially occurs in the Endoplasmic reticulum (ER) before continuing in the Golgi 
apparatus, conversely O-linked takes place exclusively in the Golgi. Secondly N-linked 
glycosylation involves a linkage between a hydroxyl group of an N-acetylglucosamine (GlcNAc) 
carbohydrate molecule and an amide nitrogen atom of an asparagine amino acid residue after 
recognition of an Asn-X-Ser/Thr consensus sequence, X being any amino acid besides proline [9]. 
By contrast O-linked glycosylation is the attachment of a carbohydrate to the oxygen atom of a 
serine or threonine amino acid residue with site specific sequence recognition more poorly 
characterised. 
N-linked glycosylation is a multi-step procedure which begins following the formation of a lipid-
carbohydrate structure, specifically a dolichol-linked N-acetylglucosamine in the ER. This then 
becomes the basis for subsequent monosaccharide addition initially on the cytoplasmic face of 
the ER, followed by within the ER luminal face until an oligosaccharide precursor structure is 
synthesised. An oligosaccharyltransferase enzyme is responsible for transferring the precursor to 
an asparagine residue of a polypeptide chain residing in the ER after consensus sequence 
recognition [10]. Once the precursor is covalently linked to the amino acid, upon correct protein 
folding, 3 glucose residues are trimmed from the glycan by glucosidase enzymes [10]. This is a cue 
for protein transit from the ER to the Golgi where further glycan processing occurs. Once fully 
synthesised, N-glycans can be structurally sub-divided into 3 main types based on the 
monosaccharide compositions of the glycan in question. All 3 forms share a common core 
structure of 2 GlcNAc and 3 mannose residues (Figure 1A) with the high mannose N-glycan form 
only possessing recurring mannose units following this core structure. Conversely a complex N-
glycan is made up of various different carbohydrate residues as well as a hybrid N-glycan which is 
a combination of the previous forms (Figure 1A). There is a vast diversity of glycan structures in 
terms of their structure leading to a great extent of heterogeneity. The examples shown in Figure 
1A are just to highlight the different structural subtypes N-glycans are classified into, in reality 
there are many more glycan structures which fit into the category of high mannose, hybrid or 
complex. 
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By contrast the mechanism for O-linked glycosylation is not so well understood. Unlike N-linked 
glycans with a precursor core, O-glycan cores are much more heterogeneous as they can be 
composed of various different carbohydrate residues. O-glycans are classified based on the first 
monosaccharide residue attachment such as O-GalNAc (N-acetylgalactosamine)or O-Fuc (Fucose) 
which are subsequently elongated and modified to form an array of glycan structures (Figure 1B). 
O-glycans are prevalent on various molecules including mucins, proteoglycans and collagen [11, 
12].  
 
 
 
 
  
 
 
 
 
Figure 1. N-glycan and O-glycan structures: A) N-glycan structural subtype examples, from left to 
right; High mannose, hybrid and complex forms. B) Mucin-type O-linked glycan cores in mammals 
[38] 
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1.2 Golgi vesicle trafficking and The Conserved Oligomeric Golgi (COG) complex 
Glycosylation chiefly takes place in the Golgi apparatus, an organelle which can be structurally 
described as an assemblage of flattened membranes termed cisternae. The cisternal 
compartments residing throughout the Golgi are organised in a specific manner based on the 
internal compositions of each. The earliest Golgi cisterna is known as the cis Golgi which is 
followed by the medial then trans Golgi ending at the latest compartment the trans-Golgi 
network. Residing within each cisternal layer are Golgi resident proteins, particularly in the 
interest of glycosylation, these include glycosylation enzymes [13].  
A broad array of glycosylation enzymes have been identified, all of which can be categorised into 
two main groups; glycosidases and glycosyltransferases. The former is responsible for glycan 
trimming and the latter that of monosaccharide addition. Specific glycosylation enzymes are 
localised to particular cisternal compartments as they are involved at different stages of glycan 
processing. For instance enzymes found localised to the medial Golgi are involved at intermediate 
stages of glycan processing such as α1, 3-1,6 mannosidase II [14] , whereas those found residing at 
the trans Golgi like α2, 6 sialyltransferase process glycans at a much later stage [14]. Therefore it 
is the non-uniform distribution of glycosylation enzymes throughout the Golgi which determines 
subsequent glycosylation patterns and finalised glycan structures. 
Various models have been proposed to suggest the movement of resident protein cargo through 
the Golgi which subsequently determines the distribution of glycosylation enzymes throughout 
the Golgi. A widely accepted model of such movement is cisternal maturation which depicts that 
proteins destined for transport to the Golgi, upon correct folding, are packaged into transport 
vesicles coated in a COPII (Coat Protein II) protein coat which targets vesicles from the ER to the 
cis Golgi face in an anterograde fashion [15]. These vesicles subsequently fuse with retrograde 
travelling vesicles coated in a COPI (Coat Protein I) protein coat which contain recycled cis Golgi 
resident proteins from an older cis Golgi. This results in the formation of a new cis Golgi 
subsequently allowing for cis Golgi specific glycosylation modifications to occur [15]. This cisterna 
will progressively mature later forming medial, trans and trans-Golgi network compartments via 
the same mechanism of retrograde recycling. At which point proteins will be fully glycosylated at 
the trans-Golgi network and are packaged into vesicles destined for functional roles elsewhere. It 
should be stressed that cisternal maturation is a highly dynamic process with new cisternae 
constantly forming due to recycling of Golgi resident proteins. The cisternal maturation model has 
evidence to support the claim for this mechanism of vesicle trafficking in the Golgi, including 
observations of enriched Golgi resident proteins in COPI vesicles over newly synthesised proteins 
[16] which contradicts the two-way vesicle transport system proposed by the vesicular transport 
model. 
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A process termed vesicle trafficking generates the non-uniform distribution of glycosylation 
enzymes between cisternae by maintaining cargo sorting into vesicles as well as vesicle targeting 
itself. Vesicle trafficking can be subdivided into different phases; budding, transport, tethering 
and fusion. Budding initiates trafficking via the release of a vesicle from a donor membrane 
compartment followed by transport away. Following this comes tethering which involves the 
capture of a vesicle from a target membrane and subsequently mediating its migration to a target 
membrane compartment. Finally fusion occurs where stable SNARE (Soluble NSF Attachment 
Protein Receptor) complexes form tightly, connecting the vesicle to the membrane. This allows for 
vesicle contents to be incorporated into the target membrane while a SNARE complex comprised 
of a membrane bound t-SNARE (target-Soluble NSF Attachment Protein Receptor)  and vesicle 
bound v-SNARE (vesicle-Soluble NSF Attachment Protein Receptor)  ensures energy provision for 
fusion. During Golgi vesicle trafficking a plethora of proteins are involved in mediating each step 
such as the coiled-coil proteins GMAP-210 (Golgi Microtubule-Associated Protein 210) and 
GM130 (Golgi Matrix Protein 130) involved in tethering at the ER-Golgi interface [17]. One of the 
main families of proteins involved in regulating all steps of vesicle trafficking are the Rab GTPases. 
These proteins cycle between inactive guanosine diphosphate (GDP) and active guanosine 
triphosphate (GTP) bound forms [60]. Rabs will sequentially interact with various effectors 
allowing them to mediate vesicle trafficking steps from budding to fusion. The sequential events 
facilitating Rab membrane recruitment and activation firstly involve Rab escort proteins (REPs) 
which function to deliver Rabs to their appropriate membrane destination [60]. Following Rab 
delivery Guanine nucleotide exchange factors (GEFs) trigger the exchange of GDP for GTP thereby 
causing Rab activation [60]. GTP hydrolysis is accelerated through GTPase activating proteins 
(GAPs) before the Rab is sequestered into the cytosol through recognition by GDP dissociation 
inhibitors (GDIs) for the cycle to repeat again [60]. These, amongst other players, are critically 
important in the correct cisternal compartmentalisation of glycosylation enzymes to ensure 
proper glycosylation takes place (Figure 2A). 
 
 
 
 
 
 
 
15 
 
 
                                                 
 
 
 
 
 
 
 
Figure 2. Schematic of budding, transport, tethering and fusion during intra-Golgi vesicle 
trafficking and Conserved Oligomeric Golgi (COG) structure: A) Golgi vesicle trafficking steps. B) 
Conserved Oligomeric Golgi (COG) complex structure; lobe A (pink) lobe B (orange) 
Rab GTPases and coiled-coiled tethers have been implicated to work in concert with various other 
proteins in order to achieve vesicle tethering. The Conserved Oligomeric Golgi (COG) complex is a 
multi-subunit tethering complex (MTC) localised to the Golgi apparatus shown to be involved in 
tethering [23]. Structurally COG is a hetero-octameric, bi-lobed complex with COG subunits 1-4 
forming lobe A and 5-8 comprising lobe B, subunits Cog1 and Cog8 form an interconnected dimer 
between each lobe [23] (Figure 2B). Lobe A is proposed to function at early stages of glycan 
processing compared to lobe B at a later stage based on findings of defective lobe A and B 
subunits affecting levels of different Golgi resident proteins respectively. Levels of early 
glycosylation enzyme mannosidase II were affected in lobe A defective cells [21], whereas 
evidence suggests levels of late enzymes galactosyl and sialyltransferase are sensitive to lobe B 
defects following observations of reduced galactosylation and sialylation in Cog7 mutant patients 
[22]. 
B)
) 
A) 
trans 
medial 
cis 
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The implication of COG in vesicle tethering has been largely elucidated based on findings of COG 
subunit interactions with a variety of proteins known to function in vesicle trafficking (Figure 3).  
 
Figure 3. Mammalian COG subunit interactions with vesicle trafficking proteins: Rab GTPases 
(yellow), SNAREs (blue), tethers (purple), coat and motor proteins (red) [23] 
Based on reported interactions, various models have been suggested to operate sequentially as to 
how COG may assemble with other proteins in aid of vesicle trafficking. The docking station 
assembly model depicts COG as an orchestrator of protein assembly at an acceptor membrane, 
including Rab GTPases and coiled-coil tethers. In agreement with this model are observations of 
Cog4 recruiting COG subunits, cis-Golgi Rabs and the coiled-coil tether p115 to STX(Syntaxin)5 
membranes, as well as Cog8 recruitment of lobe B components and trans-Golgi Rab6 to STX16 
membranes [23].  The SNARE stabilisation model suggests a successive step in that COG later acts 
to mediate stable SNARE complex assembly through multi-pronged binding to pre-formed t- 
and/or v- SNAREs. In support of this model are observations of COG-deprived cells causing a 
decrease in steady state levels of Golgi-operating SNARE complexes as well as COG interactions 
with SNARE-associated proteins such as Cog4 with STX5 partner protein Sly1 to stabilise SNARE 
complexes [24].  A further model highlights another part for COG to play in this puzzle as a direct 
facilitator of vesicle tethering by bridging the space between a vesicle and acceptor membrane 
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through simultaneous interactions with Rab GTPases, coiled-coil tethers and SNARE proteins. 
Indeed supporting this suggestion are yeast and mammalian cells deficient in COG subunits which 
were found to accumulate non-tethered vesicles composed of recycled Golgi components [25]. 
Additionally there is evidence of an immobilised COG complex directly binding to intra-Golgi 
vesicles [27] as well as observed COG subunit interactions to COPI coat components [26]. 
Formation of a bridge-like connection between vesicles and membrane compartments could be 
explainable by the structure of COG. Indeed electron micrographs have shown COG displays a 
tentacular-like morphology [27] (Figure 4) which is explainable by the fact that COG subunits are 
composed of elongated helical bundle domains, permitting extended tentacle protrusions [20]. 
Such an elongated structure potentially allows for extended connections between COG subunits 
and various trafficking proteins thereby directly mediating vesicle tethering. The successive COG 
interactions described with multiple trafficking partners have shed light onto the roles of COG in 
vesicle trafficking; further studies into these aspects will certainly substantiate evidence for the 
mechanisms proposed by the aforementioned models. 
 
 
 
 
 
 
 
Figure 4. Electron micrographs of fixed and unfixed COG conformations: Native COG purified 
from bovine brain, Fixed compact COG structure upon glutaraldehyde fixation of 10 µg/ml COG 
solution mixed with 7% glutaraldehyde (bottom), unfixed COG where glutaralyehyde fixation was 
omitted displaying tentacular protrusions (top) [37] 
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1.3 Drosophila melanogaster; a model organism for glycosylation 
Utilising model organisms as a molecular tool to study biological effects at a whole organism level 
provides a distinct advantage over using in vitro approaches. This is because specific mutations 
could impact an organism in a variety of different ways which may easily be overlooked when 
analysing localised effects in vitro. Whereas in vivo experimentation provides evidence on how a 
particular deviation from the norm via mutation could impact an organisms behaviour. With 
glycosylation being a rather complex procedure having implications in cell-cell and cell-tissue 
interactions, using Drosophila melanogaster as a model organism provides a simple, manipulative 
system in which to look at effects of mutations on glycosylation homeostasis and Drosophila 
behaviour. This offers a distinct advantage over using simple cell culture based methods which 
overlook organism-wide effects, allowing for in vivo roles of glycans to be analysed. 
Drosophila melanogaster has and continues to be one of the most widely used model organisms 
in biological research. This is a useful system for many reasons, including their short generation 
time and lifespan, high fecundity, and simple genome. Indeed Drosophila share high sequence 
homology with humans at both the DNA and protein level including around 75% known human 
disease related genes conserved in the Drosophila genome [28]. Moreover many proteins key to 
regulating vesicle trafficking are conserved between mammalian and fruit fly systems including 
subunits of the COG complex and Rab GTPases.  
Although there are many similarities between Drosophila glycosylation and that of mammalian 
systems, it is worth noting differences between the two. Despite Drosophila having both hybrid 
and complex N-glycans, these are relatively rare and they predominantly produce high mannose 
and small high mannose oligosaccharide forms known as paucimannose glycans. This is 
attributable to the fact that invertebrates lack many of the glycosylation enzymes known to 
process more complex forms of N-glycans in mammalian systems. A key enzyme implicated in the 
lack of complex and hybrid forms of N-glycans in Drosophila is a β-N-acetylglucosaminidase 
named fused lobes (Fld) which functions to remove terminal GlcNAc residues [29]. In vertebrates 
additional GlcNAc residues are maintained on the N-glycan chain allowing for elongation of 
elaborate branching structures from the trimannosyl core; whereas in Drosophila due to GlcNAc 
cleavage such elongation cannot frequently occur. Indeed mutations in Fld lead to more hybrid 
and complex N-glycan forms in Drosophila which were more representative of those seen in 
vertebrates [29]. Another difference between vertebrate and invertebrate N-glycans is the 
possibility for fucosylation linkages to comprise a modified glycan core. Vertebrate N-glycan cores 
have the potential for a 1-6 fucosylated linkage on the core GlcNAc of the glycan. However in 
invertebrate systems there is not only the capacity for 1-6 linkages, but also a 1-3 core fucosylated 
linkage (Figure 5).  
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Mucin type O-glycans have also been found to be functionally implicated in Drosophila, for 
example RNAi of individual genes encoding enzymes in the pgant family of GalNAc transferases 
were found to cause cellular morphological and functional changes, including pgant3, pgant6 or 
pgant7 effects on secretion [55].  Also RNAi of pgant3 and pgant6 induced changes of Golgi 
morphology suggesting a key role for O-glycosylation in maintaining proper secretory apparatus 
structure and function [55]. Moreover, in Drosophila RNAi of other members within the pgant 
enzyme family have been shown to cause lethality in vivo implicating them in viability [56]. 
 
 
 
                                                                                                              
 
 
 
 
 
Figure 5. Core-fucosylated N-glycans: Mammalian-like glycan with 1-6 linkage (left), Drosophila-
like glycan with 1-6 and 1-3 linkage (right) 
1.3.1 Glycan function in Drosophila muscle  
Proper glycosylation is important for muscular development and contraction in eukaryotic life. An 
instance of N-glycan significance in Drosophila muscle is shown where the N-glycan processing 
enzyme in Drosophila MGAT1 (UDP-GlcNAc:α-3-D-mannoside-β1,2-N-acetylglucosaminyl-
transferase I) which has the human ortholog GlcNAc-transferase I, was found to reduce 
neurotransmitter release and perturb normal synaptogenesis at the neuromuscular junction 
when expressed as a null mutant form [33]. Moreover O-glycosylation has been show to impact 
on Drosophila muscle where mesodermal cells defective in O-glycosylation resulted in an 
impaired larval muscular system [39].  
Preliminary data has indicated COG subunit mutation has an impact on Drosophila flight ability 
(Figure 6). Notable results show significant defects in lines where mutant forms of the Drosophila 
homolog of the COG subunit Cog5 known as four way stop (Fws) were expressed as homozygotes 
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with either Cog1 and Cog2 mutations also present or the Cog1 mutation present alone. However 
balancer chromosomes are present in many of the COG mutant genotypes and therefore some of 
the defects observed could be attributable to the affect of the balancer rather than the COG 
mutation. Therefore in order to substantiate the evidence for a COG specific affect on Drosophila 
flight ability controls of COG mutants without balancer chromosomes present should be analysed. 
 
Figure 6. Flight testing of COG mutant flies: 3-5 day old flies released into a clear box with a light 
source above, scoring based on direction of flight upwards (6), horizontal (4), downwards (2), 
none (1). Fws = four way stop (Drosophila Cog5 homolog), Hom = homozygous, Het = 
heterozygous, Df = fws deletion, COG1/COG2 = COG1/COG2 mutant, TM6B and MKRS = balancer 
chromosomes. One-way ANOVA used for analysis of statistical significance, asterix represent p 
values upon sample comparison, * = p<0.05, ** = p<0.01, **** = p<0.0001, error bars represent 
standard deviation (Eric Silva, Ungar lab, unbublished data, 2013) 
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1.4 Project outline and aims 
The questions I set out to ask from the project were three-fold; firstly I wanted to address the 
query of whether mutations in COG subunits affected N- and O-linked glycan presence and 
abundance in Drosophila muscle specific cells. To set out answering this question I have been 
carrying out N- and O-linked glycan profiling using thoraces isolated from a Drosophila line with 
an absence of protein subunit Cog3 in muscle specific cells, a mutation which renders the 
organism completely flightless, as well as wild type line controls. For N-glycan analysis I have been 
using a novel enzyme PNGaseAr to cleave glycans with Drosophila-like fucosylation linkages from 
glycoproteins which other enzymes are incapable of achieving. I have been able to optimise a 
working protocol for N-glycan release for use with PNGaseAr after initially finding the enzyme was 
not compatible with the previous protocol and subsequently used this on Drosophila samples.  
The next question I wanted to answer was whether COG mutations are detrimental enough to 
protein glycosylation in Drosophila muscle to cause observable flight defects in vivo. To address 
this I have carried out various fly line crosses to generate COG mutant genotypes to test for their 
flight ability. Findings correlate with previous results suggesting certain COG subunits more than 
others play a role in regulating the processes which underpin flight muscle contraction. This aim 
ties in with the N- and O-linked glycan analysis as any flight defects observed could then be 
attributed to differences in observed glycan profiles of COG mutant Drosophila strains. Linking 
these aims could provide further evidence to implicate COG in mediating the vesicle trafficking 
essential for glycosylation and therefore subsequently affect the specific glycan structures 
synthesised which may be important for muscle-specific roles. 
The final question I wanted to address was whether COG-Rab protein-protein interactions are 
conserved between mammalian and Drosophila systems. This would certainly provide evidence 
for how effective Drosophila can be as a model organism for glycosylation studies. To answer the 
question I have used a yeast-two-hybrid approach to look at COG subunit interactions with Rab-
GTPases in Drosophila. Observations seem to suggest evolutionary conservation between various 
COG-Rab interactions as well as unveiling some interactions specific to the Drosophila system. 
Overall from the project I aim to highlight a role for COG in Drosophila protein glycosylation and 
subsequently muscle functionality, as well as provide evidence for conservation between 
glycosylation pathways in mammalian and invertebrate systems.   
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2. Materials and Methods 
2.1 Yeast-two-hybrid COG constructs 
Primers were designed against Drosophila COG subunit cDNA sequences with restriction enzyme 
cut sites present (Table 1). PCR products were generated using 30 cycles with 30 second 
elongation times per cycle and a final elongation time of 12 minutes. PCR products were PCR 
purified (QIAGEN) before restriction digest and ligation reactions. Plasmid DNA was amplified was 
in competent DH5α E.coli before DNA extraction (QIAGEN miniprep) and Sanger sequencing. 
Plasmid constructs are shown in Table 2. 
Primer name Sequence Annealing 
temp (oC) 
DmCog4Y2Hf GAGATCGAATTCATGAGTGTGCTGGAACA 51.0°C 
DmCog4Y2Hr ATCGATGGATCCCTAAAGTTGTAGCCGCTTAATG 51.7°C 
DmCog5Y2Hf AAAGGGGGATCCATGGTGACTGGAGACCCG 56.7°C 
DmCog5Y2Hr AACTGCAGGTCGACTTATGGAAGTGCCTTTAAGGCC 55.3°C 
DmCog6Y2Hf GAG ATC GAA TTC ATG AGC TCG ACG CAG G 54.8°C 
DmCog6Y2Hr AAGTC CAG ATC GAT CTA AGT GGA GGT CAG GAT 
GTG 
54.6°C 
 
Table 1. Primers used for dmCOG plasmid construct cloning 
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Plasmid name Vector Additional information 
DmCog4AD pGAD-C1 AmpR, LEU2 yeast selection, cloned with 
BamHI and EcoRI 
DmCog5AD pGAD-C1 AmpR, LEU2 yeast selection, cloned with 
BamHI and SalI 
DmCog6AD pGAD-C1 AmpR, LEU2 yeast selection, cloned with 
EcoRI and ClaI 
DmRab1BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab2BD pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab3BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab4BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab6BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab10BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab30BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
DmRab39BD (Q-L) pGBDU-C1 AmpR, URA3 yeast selection, donated by 
Rita Sinka 
 
Table 2. Plasmid constructs cloned and used for yeast-two-hybrid 
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2.1.1 Yeast-two-hybrid 
GAL4 Activation domain (AD) COG constructs and Rab GAL4 DNA Binding domain (BD) plasmids 
(donated by Rita Sinka, University of Szeged) were co-transformed into the AH109 HIS reporter 
yeast strain [44] and grown on selective plates lacking Leucine and Uracil, transformants were re-
streaked onto plates lacking Leucine and Uracil. Colonies of yeast from re-streaks were mixed and 
resuspended in autoclaved water in a 96 well plate. Alongside this a 20-fold dilution of each yeast 
sample was aliquotted aside the initial resuspension. An inoculating manifold replicator/frogger 
was soaked in ethanol and flamed before being allowed to cool next to a Bunsen flame. Once 
cooled the frogger was dipped into wells containing the yeast samples and quickly transferred 
onto plates lacking Leucine, Uracil and Histidine/Adenine. Plates were incubated at 30oC and left 
for 1 week to grow. 
2.2 PNGase deglycosylation assays         
Proteins were denatured by heating to 95oC for 5 minutes in the presence of denature solution 
(0.2% SDS, 100mM 2-mercaptoethanol). Samples were cooled on ice and briefly centrifuged at 
14,000rpm before addition of TritonX-100 (TX-100) to a concentration of 2.25%. PNGaseF and 
PNGaseAr enzymes were added and samples were incubated at 37oC. Sample buffer (5% glycerol, 
50mM Tris 50mM DTT (Dithiothreitol), 1% SDS, 0.74mM bromphenol blue) was added to samples 
before heating at 95oC for 5 minutes. Proteins were run on 10% and 15% SDS-PAGE gels and then 
Fairbanks coomassie stained45.  
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2.3 Drosophila husbandry 
Drosophila maintenance and crosses were all performed using a modified semi- defined media 
(7.5% agar, 41.8% cornmeal, 9.9% brewers yeast, 33.6% sucrose, 7.2% propionic acid) 
supplemented with anti-fungal agents at 25oC. Crosses were conducted by collecting 10 virgin 
females and 10 males and adding these to a media vial. These were left for 2 days at 25oC before 
removing adult flies; vials were left for a further 5 days and then checked morning and evening for 
progeny genotypes. Drosophila stock genotypes are shown in Table 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Drosophila stock lines; 
𝑓𝑤𝑠−GFP
CyO
 line donated (Rita Sinka, University of Szeged), Cog3RNAi 
line was acquired from the Vienna Drosophila RNAi Center (VDRC) and the Dmef2 lines were 
provided by John Sparrow (University of York) [59] 
 
 
 
 
Stock Genotype 
WT (Canton S) 
WT (White-) 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog2
TM6B
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog1
TM6B
 
𝑓𝑤𝑠p
CyO
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
 
Cog2
TM6B
 
Cog1
TM6B
 
Dmef2-GAL4 
Dmef2-GAL4 
Cog3RNAi-UAS 
𝑓𝑤𝑠 − GFP
CyO
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2.3.1 Drosophila dissections 
100 3-5 day old flies of genotypes 
𝐷𝑚𝑒𝑓2−𝐺𝐴𝐿4
𝐶𝑜𝑔3𝑅𝑁𝐴𝑖−𝑈𝐴𝑆
 , 
𝐷𝑚𝑒𝑓2−𝐺𝐴𝐿4
𝑊𝑇
,
𝐶𝑜𝑔3𝑅𝑁𝐴𝑖−𝑈𝐴𝑆
𝑊𝑇
 were anesthetised 
using CO2 and their thoraxes were dissected using a razor blade. Thoraces were kept at -20oC 
during dissections and were stored at -80oC after dissections. 
2.4 Cell lysis/protein denaturation 
Drosophila thoraces were lysed using a pellet pestle motor in 200µl lysis buffer (4% SDS, 100mM 
Tris/HCl pH 7.6, 100mM dithiothreitol). In the case of RNAseB and Fetuin proteins they were 
diluted 1:10 in lysis buffer. Samples were incubated at 95oC for 5 minutes before centrifugation at 
14,000rpm for 5 minutes. Lysate supernatants were collected and transferred to fresh microfuge 
tubes. 
2.4.1 Filter-aided N-glycan separation (FANGS) 
Samples were diluted in Urea solution (8M in 100 mM Tris/HCl pH 8.5) 1:10 using a sample: Urea 
solution ratio. 400µl of this solution was transferred to an ultrafiltration device (Milipore: Amicon 
ultra centrifugal 30K 0.5ml tubes) and centrifuged at 15,000xg, 10 minutes at a time; flow through 
was discarded after each spin. Following transfer of the total solution volume the device was 
washed once with 250µl Urea solution, 15,000xg, 10 minutes. The samples were then treated 
with 300µl 50mM iodoacetamide made up in Urea solution and incubated at room temperature 
in the dark for 15 minutes, the solution was subsequently span through at 15,000xg and flow 
through removed. 2 more washes in 250µl Urea solution, 15,000xg, 10 minutes were carried out 
before 3 washes with 250µl 20mM Ammonium Acetate pH5.5, 15,000xg, 10 minutes. The 
retained proteins in the device were then resuspended in a 100µl volume containing 20mM 
Ammonium Acetate pH5.5 and PNGaseF or PNGaseAr enzyme. The tubes were subsequently 
parafilmed tightly with fresh collection tubes added and incubated at 37oC overnight.  
2.4.2 N-glycan collection 
Tubes were centrifuged at 15,000xg, 10 minutes, followed by 2X 250µl HPLC (High Performance 
Lipid Chromatography) H2O washes at 15,000xg, 10 minutes. Flow through was then transferred 
to clean, flamed glass tubes in which samples were dried using a vacuum centrifuge. After drying 
2X 300µl HPLC H2O washes were dried down also before storage at -20oC  
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2.4.3 O-glycan release and collection 
Fresh collection tubes were added to the devices before the addition of 300µl 25% Ammonium 
hydroxide to the retained proteins in the device following N-glycan elution. The sample-
containing tubes were subsequently parafilmed tightly and incubated at 45oC overnight. Following 
incubation the devices were centrifuged at 15,000xg, 10 minutes, before washing the device twice 
using 150µl HPLC H2O at 15,000xg, 10 minutes. This volume was then transferred to clean, flamed 
glass tubes in which samples were dried using a vacuum centrifuge. After drying 2X 300µl HPLC 
H2O washes were dried down also before storage at -20oC 
2.4.4 Permethylation 
Samples in glass tubes were re-dissolved in 20 drops dimethyl sulfoxide (DMSO) using a glass 
Pasteur pipette before immediately adding 2 microspatulas of ground sodium hydroxide per 
sample. Samples were then manually agitated for 10 seconds prior to sequences of iodomethane 
addition: Firstly 10 drops were added, samples manually mixed and 10 minutes elapsed, this was 
repeated a second time before adding 20 drops and a 20 minute wait. Following this the reaction 
was quenched by adding 1ml of 100mg/ml sodium thiosulphate and immediately after adding 1 
ml dichloromethane. Samples were then vortexed for 10 seconds and centrifuged for 15 seconds 
to form an emulsion composed of two layers. Upper aqueous layers were removed and replaced 
with 1ml HPLC H2O to perform a series of washes using 10 second vortex and 15 second 
centrifugation steps as before. This was repeated several times (5+) until the organic layer was 
clear before being dried down in the vacuum centrifuge and stored at -20oC prior to mass 
spectrometry analysis. 
2.4.5 N-glycan sample spotting 
Dried down samples were re-dissolved in 20µl methanol and 2µl of solute was added to methanol 
soaked microcentrifuge tubes. This was mixed with a 1:1 and 1:2 sample:matrix ratio using 
20mg/ml 2,5-dihydroxybenzoic acid (DHB) dissolved in 30% HPLC H2O, 70% methanol. Following 
this 1µl 500mM sodium nitrate was added to the sample/matrix solutions and 2µl of each was 
spotted out onto the plate and allowed to dry. Just before samples had completely dried 0.2µl 
ethanol was added to crystals to allow for re-crystallisation to occur. 
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2.4.6 O-glycan sample spotting 
Dried down samples were re-dissolved in 20µl acetonitrile and 2µl of solute was added to 
microcentrifuge tubes. This was mixed with a 1:1 and 1:2 sample:matrix ratio using 10mg/ml 2,5-
dihydroxybenzoic acid (DHB) dissolved in 50% acetonitrile. Following this 2µl of each was spotted 
out onto the plate and allowed to dry. Just before samples had completely dried 0.2µl ethanol 
was added to crystals to allow for re-crystallisation to occur. 
2.4.7 MALDI mass spectrometry analysis 
Sample spots were analysed using a Bruker Daltonics SolariX FTMS (Fourier transform mass 
spectrometry) mass spectrometer. Calibration was carried out using a peptide mix of 6 known 
peptide masses with an m/z detection range set between 80-4000. Shots fired were 500 and laser 
power was initially set to 30% before increasing in 10% increments to improve peak resolution. 
Once peak resolution was acceptable 5 spectra were added to the sum per spot with 500 shots 
each, before saving and analysing using the DataAnalysis programme. Glycans were assigned to 
peaks which matched known glycan masses within a mass range of 0.1 daltons or less. Known 
glycan masses were determined using the ExPASy GlycoMod online tool. In order to determine 
peaks which were more likely to be definite structures, a signal to noise ratio of 3 was set and 
peaks were manually assigned by going through the DataAnalysis spectra and locating peaks 
within a 0.1 dalton range of glycan monoisotopic masses with isotope patterns of at least 2 
naturally occurring isotopes. In order to calculate overall glycan percentage abundances the sum 
intensity for all spectrum glycan peaks including monoisotopic and other isotopes was calculated. 
Then for individual glycan percentage abundances the intensity for each individual glycan was 
calculated as a percentage from the overall sum of glycan intensities in the spectrum.  
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2.5. Flight testing 
3-5 day old flies were tested separately by inserting 5 flies at a time into the centre of a clear box 
with a light source above and tape segmenting the box into different regions. The flies were 
scored based on the region of the box in which they landed in. Each group of 5 flies were tested 5 
times each before discarding and using a fresh group, 35 flies per genotype were assessed for 
their flight ability. Flight testing was carried out in the box shown in Figure 7. Statistics were done 
using SigmaPlot programme with a One Way Analysis of Variance (ANOVA). Dunn’s method of 
multiple comparisons versus the control group (WT) was used across all samples.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 7. Box used for flight test analysis: Flight scoring = upwards (6), horizontal (4), downwards 
(2), none (1) With light source above, flies inserted in the centre of the box. Light source shone 
above and flies inserted into the centre of the box 
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3. Results 
3.1 PNGaseAr vs PNGaseF: Types of N-glycan cleavage 
The fact that some Drosophila N-glycans have 1,3 core fucosylated linkages as part of their 
structure poses a challenge for removal of these glycans from Drosophila glycoproteins. This is 
because conventionally PNGaseF is used as an amidase to cleave N-glycans and this enzyme 
cannot cleave 1,3 fucosylated N-glycans and is limited to cleaving mammalian-like 1,6 fucosylated 
N-glycans. New England Biolabs (NEB) provided us with an aliquot of a novel enzyme named 
PNGaseAr which has specificity for cleaving 1,3 fucosylated Drosophila-like N-glycans as well as 
1,6 fucosylation linkages. This enzyme therefore has potential to cleave Drosophila specific N-
glycans in order for these to be analysed, a function which PNGaseF would be incapable of 
carrying out. I began by characterising the PNGaseAr enzyme to find out its capabilities and 
functional capacity.  
Firstly in order to assess which types of N-glycans the PNGaseAr enzyme was capable of cleaving 
in comparison to PNGaseF, deglycosylation assays were carried out on the high mannose 
glycoprotein RNAseB at varied pH levels. pH was varied as not only may this affect the enzymatic 
activity, but also has implications for downstream glycan analysis in terms of using a compatible 
buffer for mass spectrometry. Figure 8a shows deglycosylation reactions carried out at two 
different pH conditions (pH 8 and pH 5.5) each with 3 different concentrations of enzyme. At pH 8 
for Ar1 and Ar0.3 units there is almost no deglycosylation of RNAseB, whereas at pH5.5 for Ar1 
and Ar0.3 units the ratio of glycosylated to deglycosylated RNAseB shifts favouring more 
deglycosylation. This indicates a more stringent dependence on pH for the PNGaseAr enzyme to 
function unlike the PNGaseF enzyme which fully deglycosylates RNAseB at a pH of 5.5 or 8. The 
next step with this information in mind was to investigate a potential buffer which could be used 
at pH5.5 for downstream glycan analysis using PNGaseAr. 
As with RNAseB, deglycosylaton was also carried out on the complex N-glycan glycoprotein Fetuin 
(Figure 8b). At all concentrations tested the PNGaseAr enzyme failed to deglycosylate Fetuin at 
pH 5.5. This is in contrast to the action of PNGaseF which was able to deglycosylate Fetuin at pH 8 
and pH 5.5. These results indicate that PNGaseAr is only capable of cleaving high mannose N-
glycans whereas PNGaseF is capable of cleaving both high mannose and complex forms. In the 
context of Drosophila however this is not such an issue as they predominantly produce the high 
mannose types of N-glycan over complex forms.  
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Figure 8. PNGaseAr can cleave high mannose N-glycans but not complex glycans: A) 
Deglycosylation assay on 4µg RNAseB, treated with 1, 0.3, and 0.1 units of PNGaseF and 
PNGaseAr at pH8 (20mM Ammonium Bicarbonate buffer pH8) and pH5.5 (20mM Ammonium 
Acetate buffer pH5.5) at 37oC for 5 hours. Samples were run on 15% SDS PAGE gel. 4µg untreated 
RNAseB was loaded in lane 1 for comparison as well as unstained PageRuler ladder (10-250kDa) B) 
Deglycosylation assay on 4µg Fetuin, treated with  0.3, and 0.1 units of PNGaseF and 1, 0,3 and 
0.1 units PNGaseAr at pH8 (20mM Ammonium Bicarbonate buffer pH8) and pH5.5 (20mM 
Ammonium Acetate buffer pH5.5) at 37oC for 5 hours. Samples were run on 10% SDS PAGE gel. 
4µg untreated Fetuin was loaded in lane 1 for comparison as well as unstained PageRuler ladder 
(10-250kDa) 
 
 
 
 
 
 
B) 
A) A) 
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3.2 Ammonium acetate functionality in FANGS procedure 
To find out if a 20mM Ammonium Acetate pH5.5 buffer was compatible with downstream mass 
spectrometry analysis FANGS was carried out using PNGaseF and RNAseB. The results in Figure 9 
show N-glycan mass peaks corresponding to those of RNAseB suggesting that the buffer is 
compatible with the procedure and can therefore be used with the PNGaseAr enzyme. The peaks 
shown in Figure 9 correspond to different mass high mannose N-glycans which are present on 
different N-glycosylation sites of the RNAseB protein. These N-glycan structures make up the 
glycosylated mass of RNAseB shown in Figure 8, once these glycans have been enzymatically 
cleaved the specific masses of each glycan structure can be visualised by mass spectrometry. This 
is also an indication of enzymatic functionality in the 20mM Ammonium acetate pH5.5 buffer as 
the mass peaks of cleaved RNAseB glycans can be seen, whereas no peaks would be visible had 
there been no enzymatic activity. This procedure was repeated with PNGaseAr using the same 
amount of enzyme; however no RNAseB N-glycan peaks were shown suggesting an inhibition or 
lack of enzymatic activity during the protocol.  
 
Figure 9. 20mM Ammonium Acetate is a compatible buffer with the FANGS procedure: Matrix-
assisted laser desorption/ionization (MALDI) mass spectra following protein denaturation and 
FANGS on 50µg RNAseB using 8 units PNGaseF with a 16 hour incubation period at 37oC and 
subsequent permethylation. 
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3.3 PNGaseAr vs PNGaseF: N-glycan cleavage efficiency 
There was the possibility that the PNGaseAr enzyme lacked efficiency at N-glycan cleavage when 
compared to PNGaseF which was why no glycans were seen via mass spectrometry on RNAseB 
cleaved N-glycans. Therefore to assess this, different units of PNGaseAr and PNGaseF were used 
in deglycosylation assays of RNAseB over different time courses. The data in Figure 10 shows that 
PNGaseAr is roughly 100 times less efficient at N-glycan cleavage than PNGaseF over a 16 hour 
time course. This can be seen when comparing PNGaseAr units of 0.3 and PNGaseF units of 0.003, 
or PNGaseAr units of 0.1 and PNGaseF units of 0.001; when compared similar deglycosylation 
patterns can be observed. This implies that higher concentrations of PNGaseAr would need to be 
used in order to achieve deglycosylation comparable to that of PNGaseF. Another observation 
from this result is that PNGaseAr continues to cleave RNAseB glycans when given a longer 
incubation time. This can be seen when comparing 0.1 PNGaseAr units after 16 hours with that at 
40 hours where a clear increase in deglycosylation can be seen at 40 hours. This implies that the 
enzyme does not lose activity or denature over time and in fact continues to cleave which is a 
promising sign for its use in the FANGS procedure. 
 
 
Figure 10. PNGaseAr is ~100x less efficient at N-glycan cleavage than PNGaseF but continues to 
cleave given prolonged incubation times: Deglycosylation assay on 4µg RNAseB, treated with 
0.01, 0.003, and 0.001 units of PNGaseF and 0.3, 0.1, 0.03, and 0.01 units PNGaseAr. Samples 
were incubated for either 16 hours or 40 hours at 37oC. Samples subsequently were run on 15% 
SDS PAGE gel 4µg untreated RNAseB was loaded in lane 1 for comparison as well as unstained 
PageRuler ladder (10-250kDa) 
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3.4 PNGaseF FANGS unit requirements 
Having established the efficiency difference between the two enzymes, observing the minimum 
amount of PNGaseF required to cleave N-glycans in FANGS and subsequently still observe glycan 
peaks via mass spectrometry would give an indication as to how little PNGaseAr may need to be 
used to produce a similar result. Due to the small aliquot of PNGaseAr readily available, FANGS 
experiments were carried out using PNGaseF with decreasing unit amounts of the enzyme to 
cleave N-glycans from the same amount of RNAseB protein. FANGS was carried out on 50µg 
RNAseB using 8, 4, 2 and 1 units PNGaseF to see where the cut-off point may be for observable 
readouts of N-glycan signal following PNGaseF cleavage. The data shown in Figure 11 is 
reminiscent of that seen in the spectra using 8 units and 4 units PNGaseF unlike that of Figure 12 
which differs. The data from these figures suggests that using 2 units or above PNGaseF is 
sufficient to produce clear N-glycan peaks following FANGS on the amount of RNAseB used. 
However when down to using 1 unit PNGaseF the signal from the spectrum begins to deteriorate 
indicating that using amounts below this may be insufficient to release enough N-glycan to be 
observed via mass spectrometry.  
 
Figure 11. 2 units PNGaseF is sufficient to produce accurate N-glycan readouts via mass 
spectrometry following FANGS: MALDI mass spectra following protein denaturation and FANGS 
on 50µg RNAseB using 2 units PNGaseF with a 16 hour incubation period at 37oC and subsequent 
permethylation. 
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Figure 12. 1 unit PNGaseF causes signal decreased signal to noise ratio of N-glycan readouts via 
mass spectrometry following FANGS:  MALDI mass spectra following protein denaturation and 
FANGS on 50µg RNAseB using 1 unit PNGaseF with a 16 hour incubation period at 37oC and 
subsequent permethylation.  
3.5 PNGase SDS sensitivity 
In order to assess what could be causing PNGaseAr inhibition during the FANGS procedure, 
different elements of the protocol were removed or altered to see if this had an effect on 
PNGaseAr cleavage of N-glycans. A few factors were tested such as the removal of the alkylating 
agent iodoacetamide from the procedure and also changing the reaction vessel for the cleavage 
from the ultrafiltration device to a microfuge tube. These factors however showed minimal 
effects if any on PNGaseAr activity and were therefore not pursued further. The results in Figure 
13 show the effect of SDS on PNGaseF and PNGaseAr activity using a 100-fold difference between 
the concentrations of the enzymes to normalise the activities of each based on the results in 
Figure 10. The effect of SDS on PNGaseAr activity was investigated as this is a component of the 
lysis buffer used prior to FANGS and it is known that SDS causes an inhibition of PNGaseF activity 
[46] and therefore could also impact PNGaseAr function. Figure 13 shows that in the F0.001 
section between 0.03-0.27% SDS high to full levels of deglycosylation occur before an increase to 
0.81 and 2.43% SDS where deglycosylation is inhibited. In the Ar0.1 section high to full levels of 
deglycosylation do not occur until 0.09% SDS which is most likely due to the PNGaseF enzyme 
being actually more than 100X higher in cleavage efficiency than PNGaseAr. Between 0.09 and 
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0.81% SDS, PNGaseAr is capable of complete deglycosylation before an increase to 2.43% where 
inhibition occurs. These results indicate firstly that PNGaseAr is better at cleaving N-glycans from 
more native protein forms than PNGaseF shown by comparing the two enzymes at 0.09% SDS 
where PNGaseAr showed slightly greater deglycosylation. Also the data shows that PNGaseAr is 
less sensitive to SDS than PNGaseF which can be seen when comparing the enzymes at 0.81% SDS 
where PNGaseAr can still fully deglycosylate whereas PNGaseF activity is inhibited. Finally it is 
evident that PNGaseAr is sensitive to SDS inhibition albeit at a higher concentration than PNGaseF 
sensitivity which is shown at a 2.43% SDS concentration. This was therefore evidence that SDS 
could be effecting the PNGaseAr activity in FANGS consequently resulting in no or insufficient N-
glycan cleavage to be visualised by mass spectrometry; so this was subsequently pursued further.  
 
Figure 13. PNGaseAr is sensitive to SDS: Deglycosylation assay on 4µg RNAseB, treated with 
0.001 units PNGaseF and 0.1 units PNGaseAr. Denature solution was composed of increasing 
concentrations of SDS to give final reaction volume concentrations of 0.03%, 0.09%, 0.27%, 0.81% 
and 2.43%. Samples were incubated for 16 hours at 37oC. Samples subsequently were run on 15% 
SDS PAGE gel. 4µg untreated RNAseB was loaded in lane 1 for comparison as well as unstained 
PageRuler ladder (10-250kDa) 
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3.6 Impact of SDS during FANGS 
After observing the sensitivity of PNGaseAr to SDS from a deglycosylation assay, taking this into 
the FANGS procedure was the next step. Lower concentrations of SDS were used in the lysis 
buffer at the start of the protocol and compared to the 4% SDS used previously. The results in 
Figure 14a show that following FANGS when using SDS concentrations of lysis buffer at 2% or 1% 
when compared to the 4% used previously, a marked improvement in PNGaseF cleavage of 
RNAseB N-glycans was seen. However the samples were also treated with TX-100 as this functions 
to counteract any SDS which may be present in the reaction to cause an inhibition of enzyme 
activity. In Figure 14b TX-100 was not added to the samples given 4% and 2% SDS concentrations 
in the lysis buffer and this resulted in no deglycosylation of RNAseB by PNGaseF suggesting that 
TX-100 is needed to counteract residual SDS activity (‘NO FANGS’ samples were used as a positive 
control for RNAseB N-glycan cleavage using the parameters from previous assays such as those 
used in Figure 10 to show glycosylated and deglycosylated bands for comparison). This was not an 
ideal situation as TX-100 is a detergent which interferes with downstream mass spectrometry 
analysis and therefore is not desirable to have in the reaction. In order to remove the 
requirement for TX-100 addition the residual SDS present during the PNGase addition stage of 
FANGS needed to be removed more effectively. 
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Figure 14. Reduced SDS improved PNGaseF N-glycan cleavage during FANGS but requires TX-100 
addition to counteract residual SDS activity in order to function: A) Deglycosylation assay on 4µg 
RNAseB with 40µg having gone through protein denaturation and FANGS, treated with lysis buffer 
composed of 4%, 2% and 1% SDS. Samples treated with 1, 0.3, 0.1 and 0.03 units PNGaseF and 
incubated for 16 hours at 37oC. Samples subsequently were run on 15% SDS PAGE gel. 4µg 
untreated RNAseB was loaded in lane 1 for comparison as well as unstained PageRuler ladder (10-
250kDa) B) Deglycosylation assay on 4µg RNAseB with 40µg having gone through protein 
denaturation and FANGS, treated with lysis buffer composed of 4% and 2% SDS.  Samples treated 
with 0.1, 0.03, 0.01 and 0.003 units PNGaseF and were not treated with TX-100. ‘NO FANGS’ 
samples were used as a control deglycosylation assay which did not contain protein having gone 
through FANGS and had 0.2% SDS and TX-100 treatment. Samples incubated for 16 hours at 37oC 
and subsequently were run on 15% SDS PAGE gel. 4µg untreated RNAseB was loaded in lane 1 for 
comparison as well as unstained PageRuler ladder (10-250kDa) 
 
 
 
 
 
 
B) 
A) 
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3.7 Effective removal of SDS from FANGS 
A possible explanation for the difficulty in removing SDS effectively from the FANGS procedure 
was that SDS micelles form as the SDS concentration goes above the critical micelle concentration 
(CMC) for SDS. This was an issue as the micelles are larger than individual SDS molecules and 
would consequently be retained above in the FANGS ultrafiltration device being too large to go 
through the pores into the flow through. Hence the PNGase enzymatic inhibition was potentially 
being caused by residual SDS micelles retained above the filter during the N-glycan cleavage. To 
attempt to resolve this issue during the dilution in Urea solution following protein denaturation a 
1:20 dilution of the sample in Urea solution was done instead of 1:10, this was also done using 
lysis buffer containing 2% SDS rather than 4%. The result in Figure 15 shows that PNGaseF and 
PNGaseAr fully deglycosylate RNAseB N-glycans following use of this modified FANGS procedure 
and even results in greater deglycosylation than the control samples which had not gone through 
FANGS. What can be inferred from this data is that the SDS has been removed more effectively 
eliminating the requirement for TX-100 addition based on the PNGase enzymes cleaving more 
effectively. 
 
Figure 15. 1:20 dilution of 2% SDS containing lysis volume with Urea solution effectively 
removes SDS from FANGS. Deglycosylation assay on 4µg RNAseB with 40µg having gone through 
protein denaturation and FANGS, treated with lysis buffer composed of 2% SDS. Samples treated 
with 0.003, 0.001 and 0.0003 units PNGaseF and 0.3, 0.1 and 0.03 units PNGaseAr. ‘NO FANGS’ 
samples were used as a control deglycosylation assay which did not contain protein having gone 
through FANGS and had 0.2% SDS and TX-100 treatment. Samples were incubated for 16 hours at 
37oC and subsequently were run on a 15% SDS PAGE gel. 4µg untreated RNAseB was loaded in 
lane 1 for comparison as well as unstained PageRuler ladder (10-250kDa) 
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3.8 Using optimised FANGS procedure with PNGaseAr                                                                                
To finalise the optimisation of the FANGS procedure for use with PNGaseAr, 3 samples were used 
for FANGS. One as a negative control using the original FANGS protocol with 0.003 units PNGaseF 
and the other two with the procedure used on samples which underwent FANGS in Figure 15 but 
here treated with 0.003 units PNGaseF and 1 unit PNGaseAr. The spectra in Figure 16a shows as 
expected no N-glycan peaks from RNAseB following use of the original FANGS procedure with 
0.003 units PNGaseF. Figure 16b shows that with the same amount of PNGaseF but using the 
optimised protocol N-glycan peaks are apparent on the spectrum. And finally in Figure 16c it is 
clear that the procedure has been successfully optimised for use with PNGaseAr as N-glycan peaks 
are shown from the samples treated with 1 unit PNGaseAr using the optimised FANGS procedure. 
The procedure was now ready for use with Drosophila melanogaster samples. 
 
 
 
 
 
 
 
A) 
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Figure 16. N-glycan cleavage during FANGS is significantly improved for both PNGaseF and 
PNGaseAr when using the optimised procedure over the original: A) MALDI mass spectra 
following protein denaturation and original FANGS procedure on 50µg RNAseB using 0.003 units 
PNGaseF with a 16 hour incubation period at 37oC and subsequent permethylation. B) MALDI 
mass spectra following protein denaturation and optimised FANGS procedure on 50µg RNAseB 
using 0.003 units PNGaseF with a 16 hour incubation period at 37oC and subsequent 
permethylation. C) MALDI mass spectra following protein denaturation and optimised FANGS 
procedure on 50µg RNAseB using 1 unit PNGaseAr with a 16 hour incubation period at 37oC and 
subsequent permethylation. 
B) 
C) 
1579.821 
1783.919 
1579.807 
1783.901 
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3.9 Drosophila N-glycan profiling 
In order to assess how the loss of COG subunit Cog3 in muscle cells may impact on Drosophila 
glycosylation, N-glycan analysis was carried out. With the FANGS protocol optimised for use with 
the PNGaseAr enzyme, this was applied to Drosophila COG mutant line 
𝐷𝑚𝑒𝑓2−𝐺𝐴𝐿4
𝐶𝑜𝑔3𝑅𝑁𝐴𝑖−𝑈𝐴𝑆
  and wild 
type control lines 
𝐷𝑚𝑒𝑓2−𝐺𝐴𝐿4
𝑊𝑇
 and 
𝐶𝑜𝑔3𝑅𝑁𝐴𝑖−𝑈𝐴𝑆
𝑊𝑇
 (Table 4). Both PNGaseF (4 units) and PNGaseAr 
(3units) were applied to the samples during FANGS.  
The results in Figure 17 show that predominantly the N-glycans detected were high mannose or 
paucimannose which is expected in Drosophila. Most of the glycans did not differ largely between 
the mutant and wild type lines; however there were a few differences. Interestingly the glycan 
HexNAc3Hex3Fuc3NeuAc1 showed an increased abundance in the mutant compared to wild type 
lines. Additionally this glycan structure was most likely cleaved by PNGaseAr due to the multiple 
fucosylation linkages in the structure suggesting a unique Drosophila-like glycan was observed 
due to use of PNGaseAr. Additionally this N-glycan structure was not previously seen in N-glycan 
profiling when using PNGaseF for glycan cleavage (Personal communication, Daniel Ungar). Other 
differences include an increase in Hex8 high mannose glycan in the mutant line as well as no 
presence in the mutant of HexNAc3Hex5.  
Carrying out tandem mass spectrometry on these structures would certainly shed more light onto 
the monosaccharide linkages of each structure. Also more repeats of each sample may unveil 
more differences in the glycan abundances between the Cog3 mutant and wild type lines. The 
glycans which differed between the mutant and wild type flies may have functional roles in 
Drosophila flight muscle. This is because with the Cog3 mutant used in this experiment having a 
flightless phenotype, differences in glycan abundances could be attributable to defective COG 
localisation of glycosylation enzymes at the Golgi consequently resulting in improper glycosylation 
of proteins important for muscular function. Hence the functionality of these proteins may be 
dependent on specific glycosylation patterns which are altered, potentially impacting cell-cell or 
cell-tissue interactions which are crucial for muscle contractile homeostasis.
43 
 
 
Figure 17. Absence of COG3 in Drosophila muscle reveals differences in N-glycan profile in comparison to wild type lines: N-glycan percentage 
abundances from MALDI MS (Mass Spectrometry) analysis following cell lysis and optimised FANGS procedure on 100 flies per genotype performed in 
triplicate using 3 units PNGaseAr and 4 units PNGaseF with a 16 hour incubation period at 37oC and subsequent permethylation.
Mannose 
GlcNAc 
Fucose 
NeuAc 
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3.10 Drosophila O-glycan profiling 
To complement the findings in Figure 17 regarding altered glycosylation shown by differences in 
N-glycan abundance between the Cog3 mutant and wild type strain, after Drosophila N-glycan 
release and collection, O-glycans were sequentially released. This gave a broader range of glycan 
species which is attributable to the fact that O-glycans have heterogeneous core structures 
opening up more possibilities for glycan structures than N-glycans. 
Figure 18 shows the O-glycan percentages in the Cog3 mutant compared to the wild type controls 
and unveils differences in glycan abundance. Glycans which showed increased abundance in the 
Cog3 mutant compared to the wild types were Xyl2NeuAc1 HexA1, Hex1HexNAc2NeuAc1, 
Hex1Fuc2KDN (Deaminoneuraminic acid)1 and Fuc1Xyl3. Also there were some glycan structures 
which had reduced abundances in the Cog3 mutant when compared to wild types which were 
HexNAc3 and Hex1Fuc1NeuAc1. It is worth noting that some of the glycan structures when 
analysed using the ExPASy GlycoMod tool were of a similar mass to various other structures. 
Therefore glycans were selected based on reported Drosophila glycosylation enzymes in the 
literature which would permit certain structures to be synthesised [47, 48].  
In the case of these glycans tandem mass spectrometry would help to reveal the monosaccharide 
linkages of the glycans in question. Overall both Figure 17 and Figure 18 suggest that the loss of 
COG subunit Cog3 has an impact on the glycosylation machinery causing differences in the 
abundance of certain glycan structures in comparison to the wild type. 
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Figure 18. Absence of COG3 in Drosophila muscle reveals differences in O-glycan profile in comparison to wild type lines: O-glycan percentage 
abundances from MALDI MS analysis following cell lysis and optimised FANGS procedure on 100 flies per genotype in triplicate with a 16 hour incubation 
period at 45oC and subsequent permethylation.
Galactose 
GalNAc 
Fucose 
NeuAc 
HexA 
KDN 
46 
 
 
Table 4. Drosophila crosses between ’Genotype 1’ and ‘Genotype 2’ to generate ‘Progeny 
genotype’ which were used in either the flight testing assay (Flight test section) or for N- and O-
linked glycan profiling (Glycan profiling section) (
𝑓𝑤𝑠−GFP
𝑓𝑤𝑠p
 and 
𝑓𝑤𝑠−GFP
CyO
 lines donated by Rita Sinka, 
University of Szeged) Cog3RNAi line was acquired from the Vienna Drosophila RNAi Center (VDRC) 
and the Dmef2 lines were provided by John Sparrow (University of York)[59] 
 
 
Flight Test 
Genotype 1 Genotype 2 Progeny genotype 
WT (Canton S) WT (White-) WT 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog1
TM6B
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog2
TM6B
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog1
Cog2
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog2
TM6B
 
𝑓𝑤𝑠p
CyO
;
+
+
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog2
+
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog1
TM6B
 
𝑓𝑤𝑠p
CyO
;
+
+
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
Cog1
+
 
𝑓𝑤𝑠p
CyO
;
+
+
 
𝑓𝑤𝑠p
CyO
;
+
+
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
+
+
 
𝑓𝑤𝑠p
CyO
;
+
+
 
WT (Canton S) 𝑓𝑤𝑠p
+
;
+
+
 
+
+
;
Cog2
TM6B
 
WT  (Canton S) +
+
;
Cog2
+
 
+
+
;
Cog1
TM6B
 
WT (Canton S) +
+
;
Cog1
+
 
+
+
;
Cog1
TM6B
 
+
+
;
Cog2
TM6B
 
+
+
;
Cog1
Cog2
 
𝑓𝑤𝑠 − GFP
CyO
;
+
+
 
𝑓𝑤𝑠p
𝑓𝑤𝑠p
;
+
+
 
𝑓𝑤𝑠 − GFP
𝑓𝑤𝑠p
;
+
+
 
Glycan profiling 
Genotype 1 Genotype 2 Progeny genotype 
Dmef2-GAL4 Cog3RNAi-UAS Dmef2 − GAL4
Cog3RNAi − UAS
 
Dmef2-GAL4 WT (Canton S) Dmef2 − GAL4
WT
 
Cog3RNAi-UAS WT (Canton S) Cog3RNAi − UAS
WT
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3.11 Flight testing 
In order to assess how defects in COG subunits may impact Drosophila flight muscle, flight testing 
was carried out on various COG mutant lines and compared to that of wild type flight; flight test 
crosses shown in Table 4. Regarding the data shown by Eric in Figure 6, although this shows flight 
defects in certain COG mutant lines, balancer chromosomes were present along with COG 
mutations. This means that the defect in flight cannot at this stage be conclusive as a COG specific 
effect as the balancer presence may be responsible for the defects observed. Therefore to tackle 
this problem fly lines were generated and tested with only COG mutations to remove the 
possibility of balancer chromosome defects. 
Flight test data is shown in Figure 18 and shows results which correlate with those seen in Figure 
6 showing that defects were indeed COG specific. Firstly it is worth noting that in all lines 
containing a 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
  mutation that showed a significant difference in flight had an observable 
hovering phenotype during the flight testing, something which other lines did not show. 
Specifically the phenotype shown was an extended period of Drosophila flight following their 
release into the box where the flies did not land on the sides of the box and maintained hovering 
flight, often gradually decreasing in flight index before eventually landing. Drosophila lines 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog1
Cog2
, 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog1
+
, 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
, 
Cog1
+
, 
Cog1
Cog2
 all showed defective flight and a significant difference in 
flight ability compared to wild type. These samples all have in common either a homozygous loss 
of Cog5 function or a lower gene dosage of lobe A subunits of the COG complex. In correlation 
with the data in Figure 6 is the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog1
Cog2
 line which showed a flight index of around 4 indicating 
horizontal flight. Moreover the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog1
+
 line also showed a similar defect to the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog1
MKRS
 line 
in Figure 6 implying that the defect in flight is specific to the COG mutations and not the balancer 
presence. Also the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog2
+
 line showed no significant difference to wild type flight which 
agrees with the flight index shown in lines 
𝑓𝑤𝑠𝑝
+
;
Cog2
+
 and 
𝑓𝑤𝑠𝑝
Df
;
Cog2
+
  in Figure 6. Lines 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
, 
Cog1
+
 
and 
Cog1
Cog2
 showed a significant difference to wild type flight unlike the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog2
+
, 
Cog2
+
 and 
𝑓𝑤𝑠𝑝
+
 
lines which agrees with the suggestion from the data in Figure 6 that the Cog2 mutation causes a 
suppression of the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
 phenotype. This data implies also that the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
 mutation causes defective 
flight and slightly less so does the 
Cog1
+
 mutation; a combination of the mutations in the  
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
;
Cog1
+
  line also maintains the flight defect, showing an additive effect on the phenotype. 
Finally the 
𝑓𝑤𝑠𝑝−𝑓𝑤𝑠:GFP
𝑓𝑤𝑠𝑝
 line which rescues the fwsp mutation to a wild type fws protein was able 
to rescue the flight defect to a wild type index. These results imply that certain COG subunit 
mutations have more of an impact on Drosophila flight ability than others. It seems that subunits 
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which have an impact on flight ability are Cog5 and Cog1 with Cog2 having no impact on flight 
ability. The effect of the Cog5 mutant on flight index can be further shown by the introduction of 
the rescue line which restores the WT phenotype by having a genotype which is effectively a 
𝑓𝑤𝑠𝑝
+
  
line with a fwsp mutation being replaced with a fws-GFP wild type Cog5 gene. These defects 
highlight potential roles in regulating glycosylation of proteins important for flight muscle 
functionality for COG subunits in both lobe A and lobe B of the COG complex. This along with the 
glycan profiling data of the Cog3 mutant line of Drosophila highlight that it only requires defects in 
individual subunits of the COG complex to disrupt the glycosylation machinery enough to alter 
glycosylation patterns and also impact on organism function, in this case muscular contraction.  
 
 
Figure 19. Mutations in fws and Cog1 Drosophila subunits cause flight defects and Cog2 
mutation suppresses the fws mutant phenotype: 3-5 day old flies released into a clear box with a 
light source above, scoring based on direction of flight upwards (6), horizontal (4), downwards (2), 
none (1).fws = four way stop (Drosophila Cog5 homolog), fwsp = four way stop p element 
disruption, + = wild type, COG1/COG2 = COG1/COG2 mutant. 35 flies were used for each 
individual flight test genotype. Significance was tested based on a one way ANOVA on ranks using 
the WT line as the control group. P values <0.05 indicates results significantly different from the 
WT score. Error bars represent standard deviation. 
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3.12 Protein-protein interactions of COG and Rab GTPases 
As a method of looking for possible interactions between Drosophila COG subunits and Drosophila 
Rab GTPases, a yeast-two-hybrid approach was used. This approach has the advantage of being 
able to investigate many different potential interactions simultaneously. The reasoning behind 
using the COG subunits and Rab GTPases chosen for this series of yeast-two-hybrid assays was 
based on the reported interactions between them in mammalian systems. The image shown in 
Figure 3 summarises these interactions, what we wanted to see was how well conserved these 
interactions would be in Drosophila to evaluate the usefulness of this system for such 
glycosylation studies.   
Firstly in Figure 19 potential interactions were analysed between various Drosophila Rab GTPases 
with the Drosophila Cog4 subunit. These results show that Drosophila Cog4 interacts with 
Drosophila Rabs 1, 2, 4, 10, 30, and 39, three of which are conserved interactions observed in 
mammalian systems between Rab1, 4 and 30 (Figure 3). This can be deduced from the growth of 
yeast colonies on the plates lacking histidine (-Leu-Ura-His) as only a protein-protein interaction 
would permit the production of histidine, subsequently allowing the yeast to grow. The premise 
behind this being a protein-protein interaction brings the GAL4AD and GAL4BD in close proximity 
as these domains are fused to the proteins of interest, and this allows for GAL4 to function as a 
transcriptional activator and drive transcription of a reporter gene responsible for encoding a 
protein crucial for yeast growth, in this case one involved in histidine biosynthesis. No protein-
protein interaction would give the opposite effect in that the GAL4AD and GAL4BD would not be 
in close enough proximity to allow GAL4 to function and therefore yeast would not grow on plates 
lacking histidine.  
The remaining interactions novel Cog-Rab interactions which are specific to Drosophila. 
Interactions were not strong enough to grow on the more stringent –Leu-Ura-Ade plate but could 
on the less stringent –Leu-Ura-His plates.  
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Figure 20. Drosophila Cog4 interacts with Drosophila Rabs 1, 2, 4, 10, 30 and 39: Drosophila Cog4 
was crossed with Drosophila Rabs 1, 2, 3, 4, 6, 10, 30, 39 and plated on control plate –Leu-Ura and 
selection plates –Leu-Ura-Ade and –Leu-Ura-His. Rab3 cross used as negative control along with 
crosses with empty vectors pGAD and pGBDU as well as positive control mCog4xmCog2 of which a 
strong mammalian interaction is known. DIL = Dilution, Q-L = GTP-locked active Rab GTPase. 
The same Rab GTPases were also crossed with Drosophila Cog5 to look for interactions between 
the Rab GTPases and the Cog5 subunit of Drosophila (Figure 20). The results indicate that 
Drosophila Cog5 interacts with Rab4, 10, 30 and 39, of which the interaction with Rab39 is also 
seen in mammalian systems (Figure 3). The interactions with Rab4, 10 and 30 are therefore 
interactions specific to Drosophila. 
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Figure 21. Drosophila Cog5 interacts with Drosophila Rabs 4, 10, 30 and 39: Drosophila Cog5 was 
crossed with Drosophila Rabs 1, 2, 3, 4, 6, 10, 30, 39 and plated on control plate –Leu-Ura and 
selection plates –Leu-Ura-Ade and –Leu-Ura-His. Rab3 cross used as negative control along with 
crosses with empty vectors pGAD and pGBDU as well as positive control mCog4xmCog2 of which a 
strong mammalian interaction is known. DIL = Dilution, Q-L = GTP-locked active Rab GTPase. 
Finally the crosses were repeated with same Rab GTPases and with Drosophila Cog6 to look for 
interactions between the Rab GTPases and the Cog6 subunit of Drosophila (Figure 21). The results 
suggest that Drosophila Cog6 interacts with Rab10, 30 and 39, of which the interaction with 
Rab10 is also seen in mammalian systems (Figure 3). The interactions with Rab30 and 39 are 
therefore interactions specific to Drosophila. 
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Figure 22. Drosophila Cog6 interacts with Drosophila Rabs 10, 30 and 39: Drosophila Cog6 was 
crossed with Drosophila Rabs 1, 2, 3, 4, 6, 10, 30, 39 and plated on control plate –Leu-Ura and 
selection plates –Leu-Ura-Ade and –Leu-Ura-His. Rab3 cross used as negative control along with 
crosses with empty vectors pGAD and pGBDU as well as positive control mCog4xmCog2 of which a 
strong mammalian interaction is known. DIL = Dilution, Q-L = GTP-locked active Rab GTPase. 
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Cog5 
x 
Rab2 
Cog5 
x 
Rab3 
Q-L 
Cog5 
x 
Rab3 
Q-L 
Cog5 
x 
Rab4 
Q-L 
Cog5 
x 
Rab4 
Q-L 
Cog5 
x 
Rab6 
Q-L 
Cog5 
x 
Rab6 
Q-L 
Cog5 
x 
Rab10 
Q-L 
Cog5 
x 
Rab10 
Q-L 
Cog5 
x 
Rab30 
Q-L 
Cog5 
x 
Rab30 
Q-L 
Cog5 
x 
Rab39 
Q-L 
Cog5 
x 
Rab39 
Q-L 
DIL DIL DIL 
-Leu-Ura -Leu-Ura-Ade -Leu-Ura-His 
DIL 
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4. Discussion 
Overall there are many things to take away from the results obtained in this project. Firstly the 
work done using PNGaseAr has characterised the efficiency and functionality of this enzyme in 
comparison to the generally used PNGaseF for N-glycan cleavage assays. As well as this not only 
has the FANGS protocol been optimised for use with PNGaseAr but PNGaseF also. Using these 
enzymes on Drosophila lacking Cog3 expression in muscle cells has shown differences in N- and O-
linked glycan profile in comparison to wild type flies. Furthermore in the flight testing analysis 
mutations in certain COG subunits has unveiled defects in flight ability compared to others. This 
can be correlated with differences in the N- and O-linked glycan profiles of the Cog3 mutant 
Drosophila line potentially attributing certain glycan structures to having functional relevance in 
Drosophila flight muscle contractile apparatus. And lastly the yeast-two-hybrid analysis has 
unveiled not only conservation with interactions observed in mammalian systems, but also novel 
interactions between COG subunits and Rab GTPase binding partners which are unique to the 
Drosophila system. 
The optimisation of the FANGS protocol has permitted the use of PNGaseAr in the FANGS 
procedure which has useful potential for future studies on Drosophila N-glycans. Indeed another 
study using the PNGaseAr enzyme has shown similarities to my data in that they observed only 
high mannose forms of N-glycans [49] as well as observing glycans with more than one fucose 
addition [49] like the GlcNAc3Hex3Fuc3NeuAc1 glycan seen in Figure 17. They did not observe 
glycans with sialyation, however for their study only cell lines were used [49] as opposed to 
segments of whole Drosophila as I used with the thoraces containing many cell types, of which 
some may have specifically sialylated glycans. But not only that, with its observed enhancement 
of PNGaseF activity due to the effectiveness of SDS removal from the procedure, this could be 
used in N-glycan studies for other systems also. Using the published FANGS protocol [40] although 
useful for removing the vast majority of N-glycans from samples and generating glycan profiles via 
mass spectrometry, this could be potentially improved by using the protocol optimised in this 
project. Indeed another group found an alternate way of optimising FANGS through using a 
coupled method with individuality normalization when labelling with glycan hydrazide tags 
(INLIGHT) [50]. However in order to directly compare my optimisation of FANGS with the 
optimisation they carried out, a comparison between the original FANGS procedure and the 
optimised version I have developed should be carried out using cell samples rather than purified 
protein as I have. The more effective removal of SDS will reduce inhibition of the PNGase enzymes 
which could allow for glycans in lower abundance which would not be cleaved and/or detected by 
mass spectrometry to appear when they wouldn’t using the previously established FANGS 
protocol.  
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Although the PNGaseAr enzyme is less efficient and has less N-glycan cleavage capacity than 
PNGaseF enzyme, it appears on the N-glycan profile that a Hex3HexNAc3Fuc3NeuAc1 glycan has 
been cleaved which could only be achieved by the PNGaseAr enzyme given the fucosylation 
linkages of the structure. This shows that the optimisation of the PNGaseAr enzyme for use in 
FANGS on the Drosophila samples was not in vein unveiling an increase in abundance of this 
glycan in the Cog3 mutant line compared to wild type. Indeed previous studies have shown the 
importance of sialylation in Drosophila muscle [41] leading to the possibility that this observed 
increase is having an impact on the flight muscle contractile apparatus and consequently flight 
ability. Not only have observations been made regarding the impact of N-glycosylation on 
Drosophila muscle through MGAT1 null effects on neuromuscular junction synaptogenesis [33], 
but also its role in Drosophila neural transmission in that N-glycan sialylation has been found to 
control neural excitability [51].  Moreover an increase of the Hex8HexNAc2 glycan was observed in 
the mutant along with an increase of Hex3HexNAc3Fuc3NeuAc1. Alterations in sialylated N-glycans 
is of interest due to its reported roles in both muscular and neurological environments. There may 
be correlation with changes in sialyation and the observations of defective flight in particular 
Drosophila COG mutant lines. As well as clear defects in Drosophila flight ability and therefore 
muscular contraction, they also displayed a landing defect by hovering for extended periods of 
time (as described in Results) possibly suggesting a neurological perturbation causing delays in 
landing times. 
The O-glycan profile unveiled some interesting alterations in glycan abundance also with an 
observed increase in glycans such as Hex1HexNAc2NeuAc1 and Hex1Deoxyhexose2HexA1 as well as 
decreases in structures HexNAc3 and Hex1Deoxyhexose1NeuAc1. The O-glycan data is comparable 
to the N-glycan profiling in that differences in glycan abundances were also observed in sialylated 
glycans. As with the N-glycan results this may point towards highlighting the role of sialylation in 
cellular events responsible for muscular contraction. Such deviations from wild type glycosylation 
patterns may point to mislocalisation of glycoslyation enzymes due to a lack of Cog3 mediated 
vesicle tethering. Indeed it has been shown previously that a deficiency of the Cog7 subunit in 
human fibroblasts leads to altered recycling of Golgi proteins [52]. It has been shown previously 
that faulty O-glycosylation also has an impact on Drosophila muscle through impaired mucin type 
O-glycosylation leading to muscle weakening and progressive degeneration [42].  Indeed the 
decrease in abundance of the HexNAc3 glycan is of interest to muscular function in that blistered 
wings has previously been observed following pgant3 mutation of RNAi, a phenotype of integrin-
mediated cell interactions which are critical in many diverse processes [57]  including muscular 
function [58].  The fact that pgant enzymes are GalNAc transferases means observations of 
differences in the HexNAc3 structure could be attributable to the mislocalisation of certain pgant 
enzymes between Golgi cisternae causing glycan processing perturbations and an 
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underproduction of the HexNAc3 glycan. This glycan structure may therefore be important as a 
cell surface glycan which mediates cell-cell or cell-tissue interactions involved in muscular 
contraction and consequently pgant mislocalisation results in impaired muscular function. 
More glycan structures both N- and O-linked may be unveiled through multiple repeats of the 
Drosophila glycan analysis as in this data set some glycans only appeared in one or two samples. 
Therefore more repeats could certainly improve the reproducibility of the data and perhaps lead 
to more glycan alterations between mutant COG and wild type lines. Moreover tandem mass 
spectrometry on the N- and O-linked glycan structures of which differences were observed 
between mutant and wild type would allow elucidation of the specific monosaccharide linkages 
which make up the glycans in question. Overall this data shows that COG has an impact on the 
glycosylation machinery at the Golgi in Drosophila and impacts the N- and O-linked glycans 
produced in muscle specific cells. 
Flight test analysis on the various COG mutant lines of Drosophila revealed certain COG subunit 
defects have a greater impact on flight muscle than others. The data suggests a Cog2 mutation 
suppression of the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
 defect in flight, reverting the flight index to a wild type-like score. 
Furthermore it seems that the 
𝑓𝑤𝑠𝑝
𝑓𝑤𝑠𝑝
 mutation is the predominant cause of a defect in flight as well 
as the 
Cog1
+
 mutation having some impact also. Moreover the rescue of the fwsp mutation leading 
to a rescue of the flight defect furthers the suggestion that the fws COG subunit plays a key role in 
regulating glycosylation of proteins involved in muscular contraction. What is useful about this 
data is the fact that there are no balancer chromosomes present in any of the genotypes meaning 
that any defect in flight can be directly correlated with mutations in COG subunits. The balancer 
chromosomes can have a significant impact in flight ability as shown in Figure 6 where the TM6B 
balancer presence in fly lines caused a severe defect in flight compared to lines which did not 
have this in their genotype. The mechanism underlying the defect in flight caused by the 
mutations in COG subunits is likely due to compromised interactions between components of the 
extracellular matrix and muscle through glycosylated proteins such as dystroglycan, a 
consequence of which is muscular dystrophy [43]. Defects in COG subunits may lead to 
mislocalised glycosylation enzymes consequently impairing the glycosylation machinery and 
thereby improperly glycosylating proteins important for interactions key to muscular function. 
This data can be correlated with differences in the N- and O-linked glycan profiles of the Cog3 
mutant Drosophila line potentially attributing certain glycan structures to having functional 
relevance in Drosophila flight muscle contractile apparatus. In combination with the glycan 
profiling results there is certainly evidence here for a role of COG in mediating the glycosylation 
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apparatus in Drosophila. Perturbations in particular COG subunits will lead to differences in glycan 
synthesis which translates to functional defects in vivo in the form of flight ability. 
Finally from the data obtained in the yeast-two-hybrid analysis it is evident that conservation 
exists between the Drosophila and mammalian systems in terms of their COG-Rab interactions. 
Levels of conservation are expected due to the high levels of sequence homology between the 
protein sequences of COG subunits and Rabs in Drosophila and mammals. Indeed it would be 
unsurprising that COG subunits would interact with Rab GTPases in Drosophila with there being 
observations in flies of Rab GTPases interacting with other vesicle tethering proteins such as 
Rab30 interactions with coiled-coil tether proteins dGCC88, dGolgin-97 and dGolgin-245 [54]. 
Cog4, 5 and 6 in Drosophila showed interactions with Rab30 and further interaction studies would 
certainly shed light onto which other potential molecular players are involved in COG-mediated 
vesicle tethering. Indeed other studies have been carried out looking at Drosophila COG-Rab 
interactions [54] which in correlation with my results showed interactions between Cog4 and 
Rab1, 2, 30 and 39, as well as between Cog6 and Rab30. However they also showed Cog5 and 
Cog6 interactions with Rab6 and Rab2 which I did not observe. I also in contrast to their results 
showed an interaction between Cog4, 5 and 6 with Rab10 and 39 of which Cog5-Rab39 and Cog6-
Rab10 interactions are conserved between the mammalian system. A possibility for some of the 
differences observed between the sets of data could be the use of the yeast-two-hybrid system 
rather than pull-down experiments, therefore in order to validate my results; further protein-
protein interaction assays should be conducted.  
 All 3 COG subunits crossed with a variety of Rabs showed at least one conserved interaction 
when compared to mammalian interactions. However interactions between COG subunits and 
Rab partners which have not been observed in mammalian studies are most likely attributable to 
differences in the protein structures which are specific to the Drosophila sequences. These have 
unveiled novel COG-Rab interactions which are unique to the Drosophila system and therefore 
they most likely have some differences in vesicle trafficking regulation in comparison to 
mammals. However having said that the conservation between some interactions highlights the 
usefulness of Drosophila to study as a model organism for vesicle tethering events and 
glycosylation patterns as a result of glycosylation enzyme trafficking. 
Overall this project has highlighted the role of COG in regulating the glycosylation machinery and 
shown the importance of this mediation in Drosophila muscular contraction. Moreover it has 
highlighted evolutionary conservation of interactions between COG subunits and Rab GTPases 
indicating the usefulness of Drosophila as a model system for glycosylation studies. Further 
studies on the impact of COG on Drosophila glycosylation and its subunit interactions with 
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different partners of vesicle trafficking can only substantiate our understanding of this intriguing 
protein complex both mechanistically in vitro and functionally in vivo. 
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Abbreviations  
AD = GAL4 Activation Domain 
AmpR = Ampicillin resistant  
ANOVA = Analysis of Variance 
BD = GAL4 DNA Binding Domain 
CDG = Congenital disorders of Glycosylation 
CMC = Critical micelle concentration 
COG = Conserved Oligomeric Golgi 
COPI = Coat protein I 
COPII = Coat protein II 
CyO = Curly wings 
Df = Deficiency 
DHB = 2,5-dihydroxybenzoic acid 
Dm = Drosophila melanogaster 
Dmef2 = Drosophila myocyte enhancer factor-2 
DMSO = Dimethyl sulfoxide  
DTT = Dithiothreitol 
ER = Endoplasmic reticulum 
FANGS = Filter-aided N-glycan separation 
FGF = Fibroblast growth factor 
Fld = Fused lobes 
FTMS = Fourier transform mass spectrometry 
Fuc = Fucose 
Fws = four way stop 
Fwsp = four way stop p element disruption 
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GalNAc = N-acetylgalactosamine 
GAP = GTPase activating protein 
GDI = GDP dissociation inhibitor 
GDP = Guanosine diphosphate 
GEF = Guanine nucleotide exchange factor 
GlcNAc = N-acetylglucosamine 
GM130 = Golgi matrix protein 130 
GMAP-210 = Golgi microtubule-associated protein 210 
GTP = Guanosine triphosphate 
Het = Heterozygous 
Hex = Hexose 
HexA = Glucoronic acid 
HexNAc = N-acetylhexosamine 
Hom = Homozygous 
HPLC = High Performance Lipid Chromatography 
INLIGHT = individuality normalization when labelling with glycan hydrazide tags 
KDN = deaminated neuraminic acid 
LEU2 = Gene encoding Beta-isopropylmalate dehydrogenase, part of leucine biosynthesis 
pathway 
MALDI = Matrix-assisted laser desorption/ionisation 
Man = Mannose 
mCog = Mammalian Cog 
MGAT = UDP-GlcNAc:α-3-D-mannoside-β1,2-N-acetylglucosaminyl-transferase I 
MKRS = Drosophila balancer 
MS = Mass spectrometry 
MTC = Multi-subunit tethering complex 
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NeuAc = Sialic acid 
pGAD = plasmid GAL4 Activation Domain 
pGBDU = plasmid GAL4 DNA Binding Domain Uracil 
PNGaseAr = Peptide N Glycosidase Ar 
PNGaseF = Peptide N Glycosidase F 
REP = Rab escort protein 
RNAseB = RibonucleaseB 
SNARE = Soluble NSF Attachment Protein Receptor 
STX = Syntaxin 
TM6B = Drosophila balancer 
t-SNARE = target-Soluble NSF Attachment Protein Receptor 
TX-100 = TritonX-100 
UAS = Upstream activation sequence 
v-SNARE = vesicle-Soluble NSF Attachment Protein Receptor 
WT = Wild type 
Xyl = Xylose 
Y2H = Yeast-two-hybrid 
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